Pacira BioSciences
PCRX
PCRX
235 hedge funds and large institutions have $1.26B invested in Pacira BioSciences in 2025 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 83 increasing their positions, 79 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
10% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 31
5% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 79
1% more funds holding
Funds holding: 233 → 235 (+2)
Holders
235
Holding in Top 10
2
Calls
$4.04M
Puts
$2.92M
Top Buyers
| 1 | +$32.5M | |
| 2 | +$31.9M | |
| 3 | +$28.1M | |
| 4 |
JGC
J. Goldman & Co
New York
|
+$18.2M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$13.2M |
Top Sellers
| 1 | -$66.1M | |
| 2 | -$28.3M | |
| 3 | -$23.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$20.3M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$14.4M |